CKD Bio Corp. (KRX:063160)
20,000
-50 (-0.25%)
At close: Jan 9, 2026
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 109.72 billion as of January 9, 2026. Its market cap has increased by 1.37% in one year.
Market Cap
109.72B
Enterprise Value
n/a
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,000.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 109.72B, an increase of 981.38%. That is a compound annual growth rate of 10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 109.99B | -1.47% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.93T |
| Celltrion | 47.48T |
| ALTEOGEN | 27.33T |
| ABL Bio | 11.27T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.46T |
| HLB Co., Ltd. | 6.66T |
| LigaChem Biosciences | 6.62T |